Avitaminosis: Clinical Trials

109 trials for Avitaminosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

80 completed, 12 unknown, 6 terminated, 5 withdrawn. 109 Phase 3, 28 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3109Completed 80, Unknown 12, Terminated 6, Withdrawn 5, Recruiting 4, Active not recruiting 2
Phase 228Completed 17, Unknown 4, Withdrawn 3, Recruiting 2, Active not recruiting 1, Terminated 1

Follow Avitaminosis: new trials by email Literature Review of Avitaminosis trials Research Report on Avitaminosis

Trials (filtered) newest first · largest first

All 109 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
Choline Chloride for Injection, Placebo - Choline Deficiency, Liver Injury
Phase 2 / Phase 3RecruitingProtara Therapeutics1292025-12-102026-08-24
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
0.75% Phentolamine Ophthalmic Solution, Placebo - Vision Loss Night, Vision Disorders
Phase 3RecruitingOpus Genetics, Inc5802025-09-022026-10-14
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances
phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist, Placebo - Mesopic Vision, Night Vision Loss
Phase 3CompletedOpus Genetics, Inc2002024-04-012026-10-26
Monthly Boluses Versus Daily Doses for Correcting Blood Vitamin D Deficit in Obese Children and Adolescents
Monthly bolus of cholecalciferol per os, Daily dose of cholecalciferol per os - Obesity, Childhood
Phase 3RecruitingHospices Civils de Lyon682023-12-042025-06-13
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
CTAP101, Placebo - Chronic Kidney Disease stage3, Chronic Kidney Disease stage4
Phase 3TerminatedOPKO Health, Inc.22023-01-312025-07-25
Vitamin D, Oxidative Stress and Inflammation in Hemodialysis
Cholecalciferol - Oxidative Stress, Inflammation
Phase 2 / Phase 3CompletedAin Shams University252022-05-152023-02-06
Cholecalciferol Supplementation in Hemodialysis Patients
Cholecalciferol - Anemia, Hemodialysis Complication
Phase 2 / Phase 3CompletedAin Shams University502022-05-152023-06-28
Effectiveness of Vitamin C Supplementation in Treatment of Rickets
Vit C - Nutritional Rickets, Bone Turnover Rate Disorder
Phase 2 / Phase 3CompletedCairo University882022-03-012023-03-08
Early Infant Micronutrition and Development
Cyanocobalamin - Vitamin B 12 Deficiency
Phase 2 / Phase 3RecruitingSykehuset Innlandet HF6002021-12-082023-04-18
Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level
Vitamin D, Artificial tear - Dry Eye Syndromes, Hypovitaminosis D
Phase 3CompletedUniversity of Faisalabad1082021-11-012022-06-21
Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCT
adhesive system, fluoride varnish, flowable composite - X-linked Hypophosphatemia (XLH)
Phase 3UnknownAssistance Publique - Hôpitaux de Paris602021-06-012021-05-05
Vitamin D Supplementation in Individuals With a Chronic Spinal Cord Injury
Cholecalciferol (Vitamin D3), Placebo - Spinal Cord Injuries, Vitamin D Deficiency
Phase 3CompletedSwiss Paraplegic Research, Nottwil502021-05-192024-03-08
The Effect of Vitamin D3 Therapy on Vitamin D Status in Pregnant Women With Vitamin D Deficient and Insufficient
Cholecalciferol - Vitamin D Deficiency
Phase 2 / Phase 3UnknownUniversitas Indonesia522021-04-012023-09-26
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
Teriparatide - Secondary Hyperparathyroidism, Chronic Kidney Disease-Mineral and Bone Disorder
Phase 3CompletedSaint Petersburg State University, Russia202021-03-012022-11-10
Anti-FGF23 (Burosumab) in Adult Patients With XLH
Burosumab - X-linked Hypophosphatemia
Phase 3CompletedWuerzburg University Hospital362021-01-072023-05-03
Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency
Calcifediol 75mcg, Calcifediol 100mcg, Calcifediol 125mcg - Vitamin D Deficiency, Vitamin D Insufficiency
Phase 2 / Phase 3CompletedFaes Farma, S.A.6742020-12-232023-09-15
Vitamin D 24'000 IU for Oral Intermittent Supplementation
Vitamin D3, Vitamin D oily capsules - Vitamin D Deficiency
Phase 3CompletedUniversity Hospital, Basel, Switzerland582019-09-302020-06-04
Effect of Thiamin Supplementation on Thiamin Status in Children With Heart Disease Receiving Diuretic Drugs
Thiamine Mononitrate - Heart Diseases
Phase 3UnknownMahidol University602019-07-012019-06-20
Rapid Normalization of Vitamin D Deficiency in PICU
Cholecalciferol, Placebo - Vitamin D Deficiency
Phase 3CompletedChildren's Hospital of Eastern Ontario4242019-06-172025-02-12
Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH
Burosumab - X-linked Hypophosphatemia
Phase 3CompletedKyowa Kirin Pharmaceutical Development Ltd352019-03-072022-05-20

Showing 20 of 109. Sign in to see all of them.

Narrower conditions

Vitamin D Deficiency (73)  ·  Vitamin A Deficiency (10)  ·  Familial Hypophosphatemic Rickets (8)  ·  Critical Illness (7)  ·  Hyperparathyroidism, Secondary (6)  ·  Renal Insufficiency, Chronic (6)  ·  Kidney Diseases (5)  ·  Osteoporosis (5)  ·  Rickets (5)  ·  Hyperhomocysteinemia (4)  ·  Hyperparathyroidism (4)  ·  Renal Insufficiency (4)  ·  Anemia (3)  ·  Breast Feeding (3)

Broader conditions

Deficiency Diseases (109)  ·  Nutrition Disorders (109)  ·  Nutritional and Metabolic Diseases (109)  ·  Malnutrition (108)  ·  Metabolic Diseases (32)  ·  Pathological Conditions, Signs and Symptoms (32)  ·  Pathologic Processes (25)  ·  Urogenital Diseases (24)  ·  Female Urogenital Diseases and Pregnancy Complications (23)  ·  Musculoskeletal Diseases (23)  ·  Female Urogenital Diseases (21)  ·  Bone Diseases (20)  ·  Bone Diseases, Metabolic (20)  ·  Calcium Metabolism Disorders (20)

Interventions

Cholecalciferol (47)  ·  Vitamin D (14)  ·  burosumab (7)  ·  Calcifediol (6)  ·  Vitamin A (4)  ·  Calcium Carbonate (3)  ·  Ergocalciferols (3)  ·  Sugars (3)  ·  Vitamin B 12 (3)  ·  paricalcitol (3)  ·  Alendronate (2)  ·  Calcitriol (2)  ·  Duration of Therapy (2)  ·  1 alpha-hydroxyergocalciferol (1)  ·  25-hydroxyvitamin D (1)

Sponsors

Johns Hopkins Bloomberg School of Public Health (4)  ·  Medical University of Graz (4)  ·  Ain Shams University (3)  ·  Kyowa Kirin, Inc. (3)  ·  Massachusetts General Hospital (3)  ·  Medical University of South Carolina (3)  ·  University of Tromso (3)  ·  American University of Beirut Medical Center (2)  ·  Centre For International Health (2)  ·  London School of Hygiene and Tropical Medicine (2)  ·  Mahidol University (2)  ·  OPKO Health, Inc. (2)  ·  OPKO IP Holdings II, Inc. (2)  ·  Opus Genetics, Inc (2)  ·  Semmelweis University (2)

Countries

United States (38)  ·  France (9)  ·  Austria (6)  ·  Canada (6)  ·  Japan (6)  ·  United Kingdom (6)  ·  Italy (5)  ·  China (4)  ·  Egypt (4)  ·  Germany (4)  ·  Norway (4)  ·  Saudi Arabia (4)  ·  Bangladesh (3)  ·  Denmark (3)  ·  South Korea (3)

Top investigators

Joel Melnick, MD (3)  ·  Alfred Sommer, M.D. (2)  ·  Amanda C Palmer, PhD (2)  ·  Tor A Strand, MD/PhD (2)  ·  Abdul Hakim Nattouf, MD, PhD (1)  ·  Adekunle Dawodu, MBBS (1)  ·  Akhtar Ashfaq, MD (1)  ·  Alain B Labrique, MSc (1)  ·  Alain B. Labrique, MSc (1)  ·  Alain Labrique, PhD (1)  ·  Albina Nowak, MD (1)  ·  Andrea Kelly, MD (1)  ·  Anke Scheel-Sailer, Dr. med. (1)

Results publications

PMID 33305842, PMID 39151033, PMID 28490513, PMID 36854566, PMID 39077939, PMID 16973975, PMID 18625626, PMID 18689371, PMID 18697901, PMID 19386744, PMID 19480654, PMID 19776145, PMID 19829124, PMID 20141576, PMID 20237066, PMID 20435345, PMID 20719580, PMID 20941903, PMID 20977661, PMID 21197089, PMID 21510905, PMID 21586714, PMID 21628633, PMID 21706518, PMID 21791335, PMID 21832026, PMID 21857221, PMID 22071710, PMID 22077475, PMID 22218721, PMID 22412025, PMID 22467697, PMID 22494826, PMID 22784845, PMID 22790678, PMID 22955514, PMID 23151532, PMID 23256143, PMID 23559082, PMID 23719555, PMID 24289974, PMID 24290111, PMID 24455219, PMID 25029424, PMID 25268295, PMID 25527663, PMID 25646326, PMID 25679979, PMID 25872802, PMID 26201817

NIH funding

2014 (1), 2018 (1), 2019 (1), K23DK087859 (1), P50AR054086 (1), R01AG019147 (1), R01DK084986 (1), R01HD043921 (1), R01HD047511 (1), R01HL069272 (1), U01HL123009 (1)